Mandate

Vinge advises Bridgepoint in conjunction with an investment in FCG

January 25, 2018

Vinge has advised Bridgepoint Development Capital in conjunction with the entry into of a partnership in FCG Holding Sverige AB.

FCG Holding Sverige AB is one of the Nordic region’s leading suppliers of specialist services within risk management, compliance, finance and capital management, financial law and corporate governance, with a focus on the financial sector.

The transaction is conditional upon approval by the Swedish Financial Supervisory Authority.

Vinge’s team primarily consisted of partner Daniel Rosvall together with associates Samra Baytar, Michaela Cronemyr, Christina Odengran and Caroline Krassén. Malin Haag and Carolina Sandell provided advice in connection with the notification to, and approval from, the Swedish Financial Supervisory Authority.

Related

Vinge has advised Vimian Group AB in connection with its uplisting to Nasdaq Stockholm

Vinge has advised Vimian Group AB (publ) in connection with its list change from Nasdaq First North Growth Market to Nasdaq Stockholm’s main market, Large cap. The prospectus was published on 21 March 2025 and the trading on Nasdaq Stockholm commenced on 28 March 2025.
March 28, 2025

Vinge advises Tribune Therapeutics in conjunction with financing round

Vinge advises Tribune Therapeutics, a Swedish biotechnology company focused on developing therapies for fibrotic diseases, in raising 23 MEUR. The financing round includes the previous investors HealthCap, Novo Holding and Innovestor, in addition to the new investors LifeArc Ventures, Industrifonden and Investinor.
March 26, 2025

Vinge advises Dignitana on the public offer from Paxman

Paxman AB (publ) has announced a public offer to the shareholders of Dignitana AB. The total value of the offer is approximately SEK 153 million.
March 24, 2025